Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging.
about
The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imagingSuper-resolution track density imaging of glioblastoma: histopathologic correlationMR diffusion tensor and perfusion-weighted imaging in preoperative grading of supratentorial nonenhancing gliomas.Advanced MR imaging techniques in the evaluation of nonenhancing gliomas: perfusion-weighted imaging compared with proton magnetic resonance spectroscopy and tumor gradeOptimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics.Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging.Simultaneous 11C-Methionine Positron Emission Tomography/Magnetic Resonance Imaging of Suspected Primary Brain Tumors.Parenchymal anaplastic astrocytoma presenting with visual symptoms due to bilateral optic nerve sheath involvementHigh-Grade Cerebral Glioma Characterization: Usefulness of MR Spectroscopy and Perfusion Imaging Associated Evaluation.Potential of high field functional MRI in the neuroradiological diagnosis of brain tumours.Usefulness of diffusion/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading?Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging.Diagnostic and Prognostic Value of 11C-Methionine PET for Nonenhancing Gliomas.Response assessment of bevacizumab therapy in GBM with integrated 11C-MET-PET/MRI: a feasibility study.Preoperative grading of supratentorial nonenhancing gliomas by high b-value diffusion-weighted 3 T magnetic resonance imaging.
P2860
Q31016200-286C9391-1A28-4267-8FE9-43678D65B36AQ33525779-59853DD0-6A83-4512-80F4-C1E42540FB55Q33595003-E0578974-8743-4A84-8842-D151B3F49059Q33812703-1A2A32AF-4B1D-4899-B42D-CA3F38590CD8Q34369508-8C3351C2-B7ED-4E47-87DF-10C9CCF876A2Q35894329-D1272AB1-7A5B-4333-BC83-7159D90CD799Q36048224-3AA4E89E-1EDA-4A68-8A00-55B6DC67A64DQ36210293-E776451B-A66F-4F0A-8B35-1969271226A5Q41958859-6E3ACCD4-1298-487D-A1FE-D5F5514D6767Q43561619-0904DB7B-0611-4C2F-B1FE-711A8A664BEFQ48383535-415DDAD0-A623-41AB-BC62-A6018C399B72Q48565954-E4AEF60A-1873-48A5-8196-F1BB1ECE8290Q48736211-98315835-A028-492B-AF0C-D82C5CD463B9Q52149108-6987CF7B-3B69-4142-94D1-293C59DA5B58Q52950126-264103EF-D0FB-4DF4-B613-60F4AC88EDF1Q55458446-2EE4B2CA-EF89-4404-AED7-A64BC1DAC116
P2860
Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Perfusion magnetic resonance i ...... al magnetic resonance imaging.
@en
Perfusion magnetic resonance i ...... al magnetic resonance imaging.
@nl
type
label
Perfusion magnetic resonance i ...... al magnetic resonance imaging.
@en
Perfusion magnetic resonance i ...... al magnetic resonance imaging.
@nl
prefLabel
Perfusion magnetic resonance i ...... al magnetic resonance imaging.
@en
Perfusion magnetic resonance i ...... al magnetic resonance imaging.
@nl
P2093
P2860
P1476
Perfusion magnetic resonance i ...... al magnetic resonance imaging.
@en
P2093
P2860
P304
P356
10.1111/J.0004-8461.2004.01315.X
P577
2004-09-01T00:00:00Z